Domestic cardiac surgery robot achieves clinical success, robot ETF Huaxia (562500) fluctuates and weakens

As of 13:44 today, the Huaxia ( 562500 ) Robotics ETF showed a pattern of initial rise followed by a decline, with oscillating downward movement after the market opened. The latest price is 0.909 yuan, down 0.329% compared to the previous trading day’s closing price. In terms of holdings, the constituent stocks tracked by this ETF exhibited clear structural differentiation: Coretech Technology hit the daily limit to lead the gains, Tianzun Technology rose over 5%, and Bojie Shares increased nearly 4%. Most constituent stocks showed mixed gains and losses, with Nanjing Power Technology falling over 3%, but overall, the index was suppressed by the weakness of heavyweight stocks. Regarding liquidity, the ETF’s trading activity significantly increased, with a turnover of 222 million yuan and a turnover rate of 1.07%, indicating strong intraday trading willingness amid the oscillating market. On the capital side, net capital inflow yesterday was 23 million yuan. The current trend is in the afternoon oscillation and decline phase, with the intraday line rising early in the session but then shifting downward and turning green, reflecting intensified battles between bulls and bears at the current position, with some selling pressure emerging above. Strategically, investors are advised to maintain strategic resolve, managing positions during the oscillation period before the trend is established. Against the backdrop of the continuous evolution of the embodied intelligence industry logic, traders can utilize the intraday oscillation window to orderly lock in high-quality, attractively valued chips, patiently waiting for the market sentiment to fully stabilize and for a sustained rebound opportunity.

In news, the Chinese Academy of Sciences Institute of Automation developed core technology for domestically produced robot-assisted transcatheter tricuspid valve replacement systems. On March 27, the first clinical cardiac valve surgery was completed at the Prince of Wales Hospital in Hong Kong. The procedure was led by a team from the Chinese University of Hong Kong Faculty of Medicine, successfully implanting a valve in a patient with severe tricuspid regurgitation, with the regurgitation disappearing post-operation and the patient recovering well.

Guotai Haitong Securities pointed out that surgical robots have significant clinical benefits, with global penetration expected to continue increasing. Domestic manufacturers’ products show outstanding clinical data, and China’s manufacturing advantages provide higher cost-effectiveness. They are expected to seize global market share through differentiated advantages.

The Huaxia ( 562500 ) Robotics ETF is the only robotics-themed ETF in the entire market with a scale exceeding 20 billion yuan. Its constituent stocks cover multiple subfields such as humanoid robots, industrial robots, and service robots, helping investors quickly deploy across the entire robotics industry chain. Off-market connection: Huaxia CSI Robotics ETF Launch-Style Connection A: 018344; Huaxia CSI Robotics ETF Launch-Style Connection C: 018345 (.

The commercialization of humanoid robots is approaching. The Huaxia ) 562500 ( Robotics ETF focuses heavily on the humanoid robot industry chain. The index-weighted stocks have significant first-mover advantages in embodied intelligence, localization of core components, and iterative mass production processes, helping investors precisely grasp the industry dividends as the robotics sector transitions from “technology verification” to “mass deployment.”